Live Breaking News & Updates on Kumar Prabhash|Page 2

Stay updated with breaking news from Kumar prabhash. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Study: Lung squamous patients harboring druggable mutations have lower median overall survival


Study: Lung squamous patients harboring druggable mutations have lower median overall survival
Oncotarget published
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.
The authors performed survival analyses of lung squamous cell carcinoma patients harboring therapeutically relevant alterations identified by whole exome sequencing and mass spectrometry-based validation across 430 lung squamous tumors.
They report a mean of 11.6 mutations/Mb with a characteristic smoking signature along with mutations in TP53, CDKN2A, NFE2L2, FAT1, KMT2C, LRP1B, FGFR1, PTEN and PREX2 among lung squamous cell carcinoma patients of Indian descent. ....

Amit Dutt , Kumar Prabhash , Emily Henderson , Oncotarget Research Output , Dutt Prabhash Research Team , Prabhash Research Team , Squamous Cell Carcinoma , Exome Sequencing , Lung Cancer , Mass Spectrometry , அமித் தத் , குமார் பிரபாஷ் , எமிலி ஹென்டர்சன் , பிரபாஷ் ஆராய்ச்சி அணி ,

4baseCare, Tata Memorial Centre to develop AI based clinical interpretation platform


4baseCare, Tata Memorial Centre to develop AI based clinical interpretation platform
4baseCare, Tata Memorial Centre to develop AI based clinical interpretation platform
09 January 2021 | News
This AI driven tool will support oncologist in clinical decision making and to offer precision medicine to cancer patients
Image credit- shutterstock.com
4baseCare, an Illumina Accelerator backed precision oncology startup in Bengaluru and ACTREC (Advanced Centre for Treatment, Research and Education in Cancer) - Tata Memorial Centre (TMC) in Mumbai have signed a collaboration agreement for an AI driven clinical interpretation platform, ClinOme. 
The collaboration aims at making an indigenous platform to generate data insights and simplified reports to guide oncologists with personalised treatment options for treating cancer patients.   ....

Pratik Chandrani , Amit Dutt , Kumar Prabhash , Tata Memorial Centre , Centre For Treatment , Illumina Accelerator , Advanced Centre , Memorial Centre , Graphical User Interface , Memorial Hospital , பிராட்டிக் சந்திரணி , அமித் தத் , குமார் பிரபாஷ் , டாடா நினைவகம் மையம் , மையம் க்கு சிகிச்சை , இல்லுமின முடுக்குப்பொறி , நினைவகம் மையம் , நினைவகம் மருத்துவமனை ,